Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

HME Insider Trading

HME | Market Equity

Comprehensive Trading Performance Summary

The investment history of corporate insiders at HME provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2009-11-24 22:31 2009-11-23 LEENHOUTS NELSON B Director OPT+S $45.00 39,998 $1,799,818 4,089 0.0%
2009-11-16 22:43 2009-11-13 LEENHOUTS NELSON B Director SELL $43.83 2,514 $110,181 4,089 -38.1%
2009-11-12 20:04 2009-11-11 LUKEN ROBERT Officer - Senior Vice President OPT+S $43.12 8,000 $344,951 32,333 0.0%
2009-11-12 20:05 2009-11-11 LEENHOUTS NELSON B Director SELL $42.65 16,699 $712,166 6,603 -71.7%
2009-08-14 19:27 2009-08-12 LEENHOUTS NORMAN P Director SELL $40.05 24,675 $988,234 1,774 -93.3%
2009-08-12 17:58 2009-08-11 LEENHOUTS NELSON B Director SELL $40.17 15,314 $615,093 20,788 -42.4%
2009-06-08 23:03 2009-06-08 LUKEN ROBERT Officer - Senior Vice President SELL $34.06 1,051 $35,797 32,333 -3.1%
2009-03-25 22:11 2009-03-24 LEENHOUTS NELSON B Director OPT+S $32.84 6,503 $213,549 34,878 0.0%
2008-11-18 22:22 2008-11-18 HELBIG LEONARD F III Director BUY $31.81 1,000 $31,810 57,715 +1.8%
2008-08-13 22:53 2008-08-11 HELBIG LEONARD F III Director OPT+S $57.15 1,781 $101,784 56,715 0.0%
2008-08-13 22:52 2008-08-12 FALK JOHANNA Officer - Senior Vice President OPT+S $55.80 14,022 $782,407 28,166 0.0%
2008-08-11 22:05 2008-08-08 TAIT AMY L Director OPT+S $55.79 12,900 $719,722 31,141 0.0%
2008-08-11 22:03 2008-08-08 LUKEN ROBERT Officer - Senior Vice President OPT+S $55.34 3,000 $166,021 25,820 0.0%
2008-08-11 22:04 2008-08-08 LEENHOUTS NORMAN P Director SELL $56.42 10,000 $564,189 35,048 -22.2%
2008-08-11 22:04 2008-08-08 LEENHOUTS NELSON B Director SELL $55.60 11,000 $611,581 35,426 -23.7%
2008-05-28 23:06 2008-05-27 LUKEN ROBERT Officer - Senior Vice President OPT+S $51.09 798 $40,770 25,820 0.0%
2008-05-21 23:29 2008-05-19 KOBER ROGER W Director SELL $51.94 3,000 $155,818 10,647 -22.0%
2008-05-20 21:38 2008-05-19 KOBER ROGER W Director OPT+S $51.87 7,000 $363,071 13,647 0.0%
2008-05-15 23:01 2008-05-14 LEENHOUTS NORMAN P Director SELL $51.45 8,265 $425,206 40,099 -17.1%
2008-04-30 21:51 2008-04-29 SMITH PAUL L Director SELL $53.04 4,000 $212,177 5,892 -40.4%
2008-03-11 23:16 2008-03-10 LEENHOUTS NORMAN P Director SELL $46.51 100 $4,651 600 -14.3%
2007-11-27 20:45 2007-11-15 HELBIG LEONARD F III Director BUY $44.93 2,000 $89,860 52,641 +3.9%
2007-05-09 21:34 2007-05-07 GOSULE ALAN L Director OPT+S $54.64 7,000 $382,461 9,900 0.0%
2007-03-30 21:37 2007-03-28 PETTINELLA EDWARD J Officer - President & CEO BUY $52.13 10,000 $521,250 184,204 +5.7%
2007-03-22 21:30 2007-03-22 LEENHOUTS NORMAN P Director OPT+S $55.90 2,000 $111,804 33,564 0.0%
2007-03-22 21:29 2007-03-20 LEENHOUTS NORMAN P Director OPT+S $55.14 4,000 $220,550 33,564 0.0%
2007-03-19 22:34 2007-03-16 LEENHOUTS NORMAN P Director OPT+S $55.41 4,000 $221,634 33,564 0.0%
2007-03-13 18:08 2007-03-09 HELBIG LEONARD F III Director SELL $55.99 2,000 $111,985 50,641 -3.8%
2007-03-13 18:09 2007-03-12 LEENHOUTS NELSON B Director SELL $55.40 900 $49,860 51,060 -1.7%
2007-03-12 23:24 2007-03-08 LEENHOUTS NORMAN P Director SELL $55.55 1,211 $67,266 33,564 -3.5%
2007-03-07 23:20 2007-03-05 SMITH PAUL L Director SELL $54.26 4,099 $222,427 8,137 -33.5%
2007-03-07 23:18 2007-03-05 LEENHOUTS NORMAN P Director SELL $55.10 6,000 $330,607 34,775 -14.7%
2007-03-07 23:19 2007-03-05 LEENHOUTS NELSON B Director SELL $55.14 3,400 $187,469 51,960 -6.1%
2007-03-05 21:48 2007-03-01 LEENHOUTS NORMAN P Director SELL $57.83 5,000 $289,162 40,775 -10.9%
2007-03-05 21:50 2007-03-02 LEENHOUTS NELSON B Director SELL $57.03 1,000 $57,028 55,360 -1.8%
2007-03-02 00:05 2007-02-28 LEENHOUTS NORMAN P Director SELL $59.20 5,000 $296,014 44,835 -10.0%
2007-02-26 18:21 2006-03-13 LEENHOUTS NORMAN P Director SELL $50.57 752 $38,029 49,835 -1.5%
2007-02-05 21:22 2006-09-05 TAIT AMY L Director SELL $56.74 4,759 $270,026 29,403 -13.9%
2006-12-04 22:25 2006-12-01 TAIT AMY L Director SELL $61.94 1,000 $61,935 5,036 -16.6%
2006-12-04 22:28 2006-11-30 FALK JOHANNA Officer - Senior Vice President OPT+S $61.83 9,413 $582,017 25,310 0.0%
2006-11-27 22:38 2006-11-22 KOBER ROGER W Director SELL $62.86 8,555 $537,767 8,976 -48.8%
2006-11-22 21:55 2006-11-21 TAIT AMY L Director OPT+S $63.01 3,500 $220,533 34,162 0.0%
2006-11-22 21:54 2006-11-21 SMITH PAUL L Director SELL $63.30 3,000 $189,897 11,058 -21.3%
2006-11-22 21:53 2006-11-20 LEENHOUTS NORMAN P Director SELL $62.73 8,597 $539,255 57,893 -12.9%
2006-11-21 21:18 2006-11-17 SMITH CLIFFORD W JR Director OPT+S $60.73 7,000 $425,093 34,746 0.0%
2006-11-21 21:16 2006-11-17 TAIT AMY L Director SELL $60.53 8,540 $516,921 2,115 -80.2%
2006-11-21 21:19 2006-11-17 LEENHOUTS NORMAN P Director OPT+S $60.30 5,000 $301,523 66,490 0.0%
2006-11-21 21:17 2006-11-17 LEENHOUTS NELSON B Director SELL $60.46 8,597 $519,742 58,752 -12.8%
2006-09-07 18:39 2006-09-06 TAIT AMY L Director SELL $56.66 2,500 $141,647 34,162 -6.8%
2006-09-07 18:40 2006-09-06 LEENHOUTS NORMAN P Director OPT+S $56.75 6,666 $378,296 70,880 0.0%
SHOW ENTRIES

How to Interpret $HME Trades

Not every insider transaction in HME is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $HME shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for HME

Insider activity data for HME is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $HME, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.